Definium Therapeutics Statistics
Total Valuation
DFTX has a market cap or net worth of $6.06 billion. The enterprise value is $5.72 billion.
| Market Cap | 6.06B |
| Enterprise Value | 5.72B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026, after market close.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DFTX has 132.74 million shares outstanding. The number of shares has increased by 19.43% in one year.
| Current Share Class | 132.74M |
| Shares Outstanding | 132.74M |
| Shares Change (YoY) | +19.43% |
| Shares Change (QoQ) | +7.71% |
| Owned by Insiders (%) | 1.82% |
| Owned by Institutions (%) | 58.92% |
| Float | 130.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 17.16 |
| P/TBV Ratio | 23.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.15.
| Current Ratio | 4.69 |
| Quick Ratio | 4.60 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.57 |
Financial Efficiency
Return on equity (ROE) is -94.70% and return on invested capital (ROIC) is -42.82%.
| Return on Equity (ROE) | -94.70% |
| Return on Assets (ROA) | -35.72% |
| Return on Invested Capital (ROIC) | -42.82% |
| Return on Capital Employed (ROCE) | -60.39% |
| Weighted Average Cost of Capital (WACC) | 16.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.24M |
| Employee Count | 106 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +448.14% in the last 52 weeks. The beta is 2.21, so DFTX's price volatility has been higher than the market average.
| Beta (5Y) | 2.21 |
| 52-Week Price Change | +448.14% |
| 50-Day Moving Average | 30.09 |
| 200-Day Moving Average | 19.23 |
| Relative Strength Index (RSI) | 66.96 |
| Average Volume (20 Days) | 4,801,640 |
Short Selling Information
The latest short interest is 14.52 million, so 10.94% of the outstanding shares have been sold short.
| Short Interest | 14.52M |
| Short Previous Month | 10.64M |
| Short % of Shares Out | 10.94% |
| Short % of Float | 11.14% |
| Short Ratio (days to cover) | 3.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -193.37M |
| Pretax Income | -237.54M |
| Net Income | -237.54M |
| EBITDA | n/a |
| EBIT | -193.37M |
| Earnings Per Share (EPS) | -$2.49 |
Balance Sheet
The company has $373.42 million in cash and $40.77 million in debt, with a net cash position of $332.65 million or $2.51 per share.
| Cash & Cash Equivalents | 373.42M |
| Total Debt | 40.77M |
| Net Cash | 332.65M |
| Net Cash Per Share | $2.51 |
| Equity (Book Value) | 278.85M |
| Book Value Per Share | 2.68 |
| Working Capital | 299.45M |
Cash Flow
| Operating Cash Flow | -144.77M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 20.00M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DFTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.43% |
| Shareholder Yield | -19.43% |
| Earnings Yield | -3.93% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for DFTX is $57.80, which is 26.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $57.80 |
| Price Target Difference | 26.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 29, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |